| 000 | 01556 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516070920.0 | ||
| 264 | 0 | _c20120911 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1439-0795 | ||
| 024 | 7 |
_a10.1055/s-0031-1297935 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaslakis, G | |
| 245 | 0 | 0 |
_aThe differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study. _h[electronic resource] |
| 260 |
_bPharmacopsychiatry _cMay 2012 |
||
| 300 |
_a96-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzodiazepines _xadministration & dosage |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHomeostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Diseases _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRisperidone _xadministration & dosage |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDeuschle, M | |
| 700 | 1 | _aThome, J | |
| 700 | 1 | _aRüsse, S | |
| 700 | 1 | _aKopf, D | |
| 773 | 0 |
_tPharmacopsychiatry _gvol. 45 _gno. 3 _gp. 96-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0031-1297935 _zAvailable from publisher's website |
| 999 |
_c21396006 _d21396006 |
||